PoplarV1, Main, Exploration, bibRecord, 001A36

25-gauge pars plana vitrectomy with medium-term postoperative perfluoro-n-octane for the repair of giant retinal tears.

Identifieur interne : 001A36 ( Main/Exploration ); précédent : 001A35; suivant : 001A37

25-gauge pars plana vitrectomy with medium-term postoperative perfluoro-n-octane for the repair of giant retinal tears.

Auteurs : John C. Randolph [États-Unis] ; Rocio I. Diaz [États-Unis] ; Eric J. Sigler [États-Unis] ; Jorge I. Calzada [États-Unis] ; Steve Charles [États-Unis]

Source :

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie [ 1435-702X ] ; 2016.

RBID : pubmed:25959143

Descripteurs français

KwdFr :
- Acuité visuelle (physiologie), Adulte (MeSH), Adulte d'âge moyen (MeSH), Complications postopératoires (MeSH), Femelle (MeSH), Fluorocarbones (administration et posologie), Humains (MeSH), Mâle (MeSH), Perforations de la rétine (chirurgie), Perforations de la rétine (physiopathologie), Période postopératoire (MeSH), Tamponnement interne (MeSH), Vitrectomie (méthodes), Études de suivi (MeSH), Études rétrospectives (MeSH).
MESH :
- administration et posologie : Fluorocarbones.
- chirurgie : Perforations de la rétine.
- méthodes : Vitrectomie.
- physiologie : Acuité visuelle.
- physiopathologie : Perforations de la rétine.
- Adulte, Adulte d'âge moyen, Complications postopératoires, Femelle, Humains, Mâle, Période postopératoire, Tamponnement interne, Études de suivi, Études rétrospectives.

English descriptors

KwdEn :
- Adult (MeSH), Endotamponade (MeSH), Female (MeSH), Fluorocarbons (administration & dosage), Follow-Up Studies (MeSH), Humans (MeSH), Male (MeSH), Middle Aged (MeSH), Postoperative Complications (MeSH), Postoperative Period (MeSH), Retinal Perforations (physiopathology), Retinal Perforations (surgery), Retrospective Studies (MeSH), Visual Acuity (physiology), Vitrectomy (methods).
MESH :
- chemical , administration & dosage : Fluorocarbons.
- methods : Vitrectomy.
- physiology : Visual Acuity.
- physiopathology : Retinal Perforations.
- surgery : Retinal Perforations.
- Adult, Endotamponade, Female, Follow-Up Studies, Humans, Male, Middle Aged, Postoperative Complications, Postoperative Period, Retrospective Studies.

Abstract

PURPOSE

The purpose of this study was to describe the treatment of giant retinal tears (GRTs) with 25-gauge pars plana vitrectomy (PPV) and medium-term postoperative perfluoro-n-octane (MT-PFO).

METHODS

The study was a retrospective interventional case series of consecutive patients with GRTs treated with 25-gauge PPV and postoperative MT-PFO for a period of 2-3 weeks. A second, staged procedure was performed in all patients for PFO removal.

RESULTS

Twenty-three eyes of 22 patients were studied, with a mean follow-up of 33.04 ± 19.74 months. Successful reattachment was achieved in 91.3 % of eyes (21/23) after MT-PFO. Retinal re-detachment occurred in five eyes, which was caused by proliferative vitreoretinopathy. Additional complications included cataract progression (n = 10), foreign body response (30.4 %, 7/23), and transient intraocular pressure (IOP) elevation (8/23, 34.8 %). Transient IOP elevation was associated with worse visual outcome (p = 0.01).

CONCLUSIONS

MT-PFO was found to be an effective and safe technique for operative management of GRTs. In the majority of patients, retinas remained attached without further surgical intervention. Cataract progression, intraocular inflammation, and associated increased intraocular pressure are potential complications of MT-PFO.

DOI: 10.1007/s00417-015-3049-4
PubMed: 25959143

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 001C98
to stream Main, to step Curation: 001C98

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">25-gauge pars plana vitrectomy with medium-term postoperative perfluoro-n-octane for the repair of giant retinal tears.</title>
<author><name sortKey="Randolph, John C" sort="Randolph, John C" uniqKey="Randolph J" first="John C" last="Randolph">John C. Randolph</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Vitreoretinal Surgery, Charles Retina Institute, 6401 Poplar Avenue, Suite 190, Memphis, TN, 38119, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Vitreoretinal Surgery, Charles Retina Institute, 6401 Poplar Avenue, Suite 190, Memphis, TN, 38119</wicri:regionArea>
<wicri:noRegion>38119</wicri:noRegion>
</affiliation>
<affiliation wicri:level="2"><nlm:affiliation>Department of Vitreoretinal Surgery, Center for Retina and Macular Disease, Winter Haven, FL, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Vitreoretinal Surgery, Center for Retina and Macular Disease, Winter Haven, FL</wicri:regionArea>
<placeName><region type="state">Floride</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Diaz, Rocio I" sort="Diaz, Rocio I" uniqKey="Diaz R" first="Rocio I" last="Diaz">Rocio I. Diaz</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Vitreoretinal Surgery, Charles Retina Institute, 6401 Poplar Avenue, Suite 190, Memphis, TN, 38119, USA. rociodiaz12@gmail.com.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Vitreoretinal Surgery, Charles Retina Institute, 6401 Poplar Avenue, Suite 190, Memphis, TN, 38119</wicri:regionArea>
<wicri:noRegion>38119</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Sigler, Eric J" sort="Sigler, Eric J" uniqKey="Sigler E" first="Eric J" last="Sigler">Eric J. Sigler</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Vitreoretinal Surgery, Charles Retina Institute, 6401 Poplar Avenue, Suite 190, Memphis, TN, 38119, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Vitreoretinal Surgery, Charles Retina Institute, 6401 Poplar Avenue, Suite 190, Memphis, TN, 38119</wicri:regionArea>
<wicri:noRegion>38119</wicri:noRegion>
</affiliation>
<affiliation wicri:level="2"><nlm:affiliation>Division of Medical and Surgical Diseases of the Retina, Vitreous and Macula, Ophthalmic Consultants of Long Island, Lynbrook, NY, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Medical and Surgical Diseases of the Retina, Vitreous and Macula, Ophthalmic Consultants of Long Island, Lynbrook, NY</wicri:regionArea>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Calzada, Jorge I" sort="Calzada, Jorge I" uniqKey="Calzada J" first="Jorge I" last="Calzada">Jorge I. Calzada</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Vitreoretinal Surgery, Charles Retina Institute, 6401 Poplar Avenue, Suite 190, Memphis, TN, 38119, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Vitreoretinal Surgery, Charles Retina Institute, 6401 Poplar Avenue, Suite 190, Memphis, TN, 38119</wicri:regionArea>
<wicri:noRegion>38119</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Charles, Steve" sort="Charles, Steve" uniqKey="Charles S" first="Steve" last="Charles">Steve Charles</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Vitreoretinal Surgery, Charles Retina Institute, 6401 Poplar Avenue, Suite 190, Memphis, TN, 38119, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Vitreoretinal Surgery, Charles Retina Institute, 6401 Poplar Avenue, Suite 190, Memphis, TN, 38119</wicri:regionArea>
<wicri:noRegion>38119</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:25959143</idno>
<idno type="pmid">25959143</idno>
<idno type="doi">10.1007/s00417-015-3049-4</idno>
<idno type="wicri:Area/Main/Corpus">001C98</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001C98</idno>
<idno type="wicri:Area/Main/Curation">001C98</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001C98</idno>
<idno type="wicri:Area/Main/Exploration">001C98</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">25-gauge pars plana vitrectomy with medium-term postoperative perfluoro-n-octane for the repair of giant retinal tears.</title>
<author><name sortKey="Randolph, John C" sort="Randolph, John C" uniqKey="Randolph J" first="John C" last="Randolph">John C. Randolph</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Vitreoretinal Surgery, Charles Retina Institute, 6401 Poplar Avenue, Suite 190, Memphis, TN, 38119, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Vitreoretinal Surgery, Charles Retina Institute, 6401 Poplar Avenue, Suite 190, Memphis, TN, 38119</wicri:regionArea>
<wicri:noRegion>38119</wicri:noRegion>
</affiliation>
<affiliation wicri:level="2"><nlm:affiliation>Department of Vitreoretinal Surgery, Center for Retina and Macular Disease, Winter Haven, FL, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Vitreoretinal Surgery, Center for Retina and Macular Disease, Winter Haven, FL</wicri:regionArea>
<placeName><region type="state">Floride</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Diaz, Rocio I" sort="Diaz, Rocio I" uniqKey="Diaz R" first="Rocio I" last="Diaz">Rocio I. Diaz</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Vitreoretinal Surgery, Charles Retina Institute, 6401 Poplar Avenue, Suite 190, Memphis, TN, 38119, USA. rociodiaz12@gmail.com.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Vitreoretinal Surgery, Charles Retina Institute, 6401 Poplar Avenue, Suite 190, Memphis, TN, 38119</wicri:regionArea>
<wicri:noRegion>38119</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Sigler, Eric J" sort="Sigler, Eric J" uniqKey="Sigler E" first="Eric J" last="Sigler">Eric J. Sigler</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Vitreoretinal Surgery, Charles Retina Institute, 6401 Poplar Avenue, Suite 190, Memphis, TN, 38119, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Vitreoretinal Surgery, Charles Retina Institute, 6401 Poplar Avenue, Suite 190, Memphis, TN, 38119</wicri:regionArea>
<wicri:noRegion>38119</wicri:noRegion>
</affiliation>
<affiliation wicri:level="2"><nlm:affiliation>Division of Medical and Surgical Diseases of the Retina, Vitreous and Macula, Ophthalmic Consultants of Long Island, Lynbrook, NY, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Medical and Surgical Diseases of the Retina, Vitreous and Macula, Ophthalmic Consultants of Long Island, Lynbrook, NY</wicri:regionArea>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Calzada, Jorge I" sort="Calzada, Jorge I" uniqKey="Calzada J" first="Jorge I" last="Calzada">Jorge I. Calzada</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Vitreoretinal Surgery, Charles Retina Institute, 6401 Poplar Avenue, Suite 190, Memphis, TN, 38119, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Vitreoretinal Surgery, Charles Retina Institute, 6401 Poplar Avenue, Suite 190, Memphis, TN, 38119</wicri:regionArea>
<wicri:noRegion>38119</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Charles, Steve" sort="Charles, Steve" uniqKey="Charles S" first="Steve" last="Charles">Steve Charles</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Vitreoretinal Surgery, Charles Retina Institute, 6401 Poplar Avenue, Suite 190, Memphis, TN, 38119, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Vitreoretinal Surgery, Charles Retina Institute, 6401 Poplar Avenue, Suite 190, Memphis, TN, 38119</wicri:regionArea>
<wicri:noRegion>38119</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie</title>
<idno type="eISSN">1435-702X</idno>
<imprint><date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult (MeSH)</term>
<term>Endotamponade (MeSH)</term>
<term>Female (MeSH)</term>
<term>Fluorocarbons (administration & dosage)</term>
<term>Follow-Up Studies (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Male (MeSH)</term>
<term>Middle Aged (MeSH)</term>
<term>Postoperative Complications (MeSH)</term>
<term>Postoperative Period (MeSH)</term>
<term>Retinal Perforations (physiopathology)</term>
<term>Retinal Perforations (surgery)</term>
<term>Retrospective Studies (MeSH)</term>
<term>Visual Acuity (physiology)</term>
<term>Vitrectomy (methods)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Acuité visuelle (physiologie)</term>
<term>Adulte (MeSH)</term>
<term>Adulte d'âge moyen (MeSH)</term>
<term>Complications postopératoires (MeSH)</term>
<term>Femelle (MeSH)</term>
<term>Fluorocarbones (administration et posologie)</term>
<term>Humains (MeSH)</term>
<term>Mâle (MeSH)</term>
<term>Perforations de la rétine (chirurgie)</term>
<term>Perforations de la rétine (physiopathologie)</term>
<term>Période postopératoire (MeSH)</term>
<term>Tamponnement interne (MeSH)</term>
<term>Vitrectomie (méthodes)</term>
<term>Études de suivi (MeSH)</term>
<term>Études rétrospectives (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Fluorocarbons</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Fluorocarbones</term>
</keywords>
<keywords scheme="MESH" qualifier="chirurgie" xml:lang="fr"><term>Perforations de la rétine</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Vitrectomy</term>
</keywords>
<keywords scheme="MESH" qualifier="méthodes" xml:lang="fr"><term>Vitrectomie</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Acuité visuelle</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Visual Acuity</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Perforations de la rétine</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Retinal Perforations</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Retinal Perforations</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Endotamponade</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Postoperative Complications</term>
<term>Postoperative Period</term>
<term>Retrospective Studies</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Complications postopératoires</term>
<term>Femelle</term>
<term>Humains</term>
<term>Mâle</term>
<term>Période postopératoire</term>
<term>Tamponnement interne</term>
<term>Études de suivi</term>
<term>Études rétrospectives</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p><b>PURPOSE</b>
</p>
<p>The purpose of this study was to describe the treatment of giant retinal tears (GRTs) with 25-gauge pars plana vitrectomy (PPV) and medium-term postoperative perfluoro-n-octane (MT-PFO).</p>
</div>
<div type="abstract" xml:lang="en"><p><b>METHODS</b>
</p>
<p>The study was a retrospective interventional case series of consecutive patients with GRTs treated with 25-gauge PPV and postoperative MT-PFO for a period of 2-3 weeks. A second, staged procedure was performed in all patients for PFO removal.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>RESULTS</b>
</p>
<p>Twenty-three eyes of 22 patients were studied, with a mean follow-up of 33.04 ± 19.74 months. Successful reattachment was achieved in 91.3 % of eyes (21/23) after MT-PFO. Retinal re-detachment occurred in five eyes, which was caused by proliferative vitreoretinopathy. Additional complications included cataract progression (n = 10), foreign body response (30.4 %, 7/23), and transient intraocular pressure (IOP) elevation (8/23, 34.8 %). Transient IOP elevation was associated with worse visual outcome (p = 0.01).</p>
</div>
<div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b>
</p>
<p>MT-PFO was found to be an effective and safe technique for operative management of GRTs. In the majority of patients, retinas remained attached without further surgical intervention. Cataract progression, intraocular inflammation, and associated increased intraocular pressure are potential complications of MT-PFO.</p>
</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25959143</PMID>
<DateCompleted><Year>2016</Year>
<Month>09</Month>
<Day>23</Day>
</DateCompleted>
<DateRevised><Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1435-702X</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>254</Volume>
<Issue>2</Issue>
<PubDate><Year>2016</Year>
<Month>Feb</Month>
</PubDate>
</JournalIssue>
<Title>Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie</Title>
<ISOAbbreviation>Graefes Arch Clin Exp Ophthalmol</ISOAbbreviation>
</Journal>
<ArticleTitle>25-gauge pars plana vitrectomy with medium-term postoperative perfluoro-n-octane for the repair of giant retinal tears.</ArticleTitle>
<Pagination><MedlinePgn>253-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s00417-015-3049-4</ELocationID>
<Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">The purpose of this study was to describe the treatment of giant retinal tears (GRTs) with 25-gauge pars plana vitrectomy (PPV) and medium-term postoperative perfluoro-n-octane (MT-PFO).</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">The study was a retrospective interventional case series of consecutive patients with GRTs treated with 25-gauge PPV and postoperative MT-PFO for a period of 2-3 weeks. A second, staged procedure was performed in all patients for PFO removal.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Twenty-three eyes of 22 patients were studied, with a mean follow-up of 33.04 ± 19.74 months. Successful reattachment was achieved in 91.3 % of eyes (21/23) after MT-PFO. Retinal re-detachment occurred in five eyes, which was caused by proliferative vitreoretinopathy. Additional complications included cataract progression (n = 10), foreign body response (30.4 %, 7/23), and transient intraocular pressure (IOP) elevation (8/23, 34.8 %). Transient IOP elevation was associated with worse visual outcome (p = 0.01).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">MT-PFO was found to be an effective and safe technique for operative management of GRTs. In the majority of patients, retinas remained attached without further surgical intervention. Cataract progression, intraocular inflammation, and associated increased intraocular pressure are potential complications of MT-PFO.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Randolph</LastName>
<ForeName>John C</ForeName>
<Initials>JC</Initials>
<AffiliationInfo><Affiliation>Department of Vitreoretinal Surgery, Charles Retina Institute, 6401 Poplar Avenue, Suite 190, Memphis, TN, 38119, USA.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Department of Vitreoretinal Surgery, Center for Retina and Macular Disease, Winter Haven, FL, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Diaz</LastName>
<ForeName>Rocio I</ForeName>
<Initials>RI</Initials>
<AffiliationInfo><Affiliation>Department of Vitreoretinal Surgery, Charles Retina Institute, 6401 Poplar Avenue, Suite 190, Memphis, TN, 38119, USA. rociodiaz12@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Sigler</LastName>
<ForeName>Eric J</ForeName>
<Initials>EJ</Initials>
<AffiliationInfo><Affiliation>Department of Vitreoretinal Surgery, Charles Retina Institute, 6401 Poplar Avenue, Suite 190, Memphis, TN, 38119, USA.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Division of Medical and Surgical Diseases of the Retina, Vitreous and Macula, Ophthalmic Consultants of Long Island, Lynbrook, NY, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Calzada</LastName>
<ForeName>Jorge I</ForeName>
<Initials>JI</Initials>
<AffiliationInfo><Affiliation>Department of Vitreoretinal Surgery, Charles Retina Institute, 6401 Poplar Avenue, Suite 190, Memphis, TN, 38119, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Charles</LastName>
<ForeName>Steve</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Department of Vitreoretinal Surgery, Charles Retina Institute, 6401 Poplar Avenue, Suite 190, Memphis, TN, 38119, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2015</Year>
<Month>05</Month>
<Day>12</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Germany</Country>
<MedlineTA>Graefes Arch Clin Exp Ophthalmol</MedlineTA>
<NlmUniqueID>8205248</NlmUniqueID>
<ISSNLinking>0721-832X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D005466">Fluorocarbons</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>6P60ZBK0QL</RegistryNumber>
<NameOfSubstance UI="C073608">perfluorooctane</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058450" MajorTopicYN="Y">Endotamponade</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005466" MajorTopicYN="N">Fluorocarbons</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011184" MajorTopicYN="N">Postoperative Period</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012167" MajorTopicYN="N">Retinal Perforations</DescriptorName>
<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
<QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014792" MajorTopicYN="N">Visual Acuity</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014821" MajorTopicYN="N">Vitrectomy</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Giant retinal tear</Keyword>
<Keyword MajorTopicYN="N">Medium-term PFO</Keyword>
<Keyword MajorTopicYN="N">Pars plana vitrectomy</Keyword>
<Keyword MajorTopicYN="N">Perfluoro-n-octane</Keyword>
<Keyword MajorTopicYN="N">Perfluorocarbon heavy liquid</Keyword>
<Keyword MajorTopicYN="N">Retinal detachment</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year>
<Month>01</Month>
<Day>21</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2015</Year>
<Month>05</Month>
<Day>01</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2015</Year>
<Month>04</Month>
<Day>28</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2015</Year>
<Month>5</Month>
<Day>12</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2015</Year>
<Month>5</Month>
<Day>12</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2016</Year>
<Month>9</Month>
<Day>24</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">25959143</ArticleId>
<ArticleId IdType="doi">10.1007/s00417-015-3049-4</ArticleId>
<ArticleId IdType="pii">10.1007/s00417-015-3049-4</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Retina. 2013 Apr;33(4):791-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23117281</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ophthalmology. 1986 Sep;93(9):1193-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3808629</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Retina. 1999;19(3):188-92</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10380022</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Ophthalmol. 2005 Sep;140(3):509-16</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16196117</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Retina. 2004 Jun;24(3):435-44</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15187667</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ophthalmology. 1983 Feb;90(2):121-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6856248</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Graefes Arch Clin Exp Ophthalmol. 1989;227(4):323-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2777101</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ophthalmic Surg Lasers Imaging Retina. 2013 Jan-Feb;44(1):34-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23418732</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Fr Ophtalmol. 1984;7(3):205-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6540279</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ophthalmology. 2001 Jan;108(1):45-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11150263</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Ophthalmol. 2003 Mar;13(2):192-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12696639</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Br J Ophthalmol. 2005 Sep;89(9):1176-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16113376</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Retina. 2008 Mar;28(3):485-92</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18327143</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Retina. 1993;13(2):136-41</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8337495</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Retina. 1986 Winter;6(4):197-204</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3575887</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Retina. 2014 Feb;34(2):237-46</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23881228</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Br J Ophthalmol. 2011 May;95(5):694-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20934993</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Retina. 2012 Jun;32(6):1114-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21968506</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ophthalmology. 2002 Oct;109(10):1828-33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12359602</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Retina. 2014 Mar;34(3):616-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24393834</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Chang Gung Med J. 2001 Oct;24(10):633-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11771186</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Ophthalmol. 1996 Jul-Sep;6(3):315-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8908440</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Retina. 2005 Oct-Nov;25(7):897-901</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16205570</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Ophthalmol. 2008 Mar-Apr;18(2):270-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18320521</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Ophthalmol. 1992 Feb;24(2):45-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1562123</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Retina. 1991;11(4):367-74</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1813951</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Floride</li>
<li>État de New York</li>
</region>
</list>
<tree><country name="États-Unis"><noRegion><name sortKey="Randolph, John C" sort="Randolph, John C" uniqKey="Randolph J" first="John C" last="Randolph">John C. Randolph</name>
</noRegion>
<name sortKey="Calzada, Jorge I" sort="Calzada, Jorge I" uniqKey="Calzada J" first="Jorge I" last="Calzada">Jorge I. Calzada</name>
<name sortKey="Charles, Steve" sort="Charles, Steve" uniqKey="Charles S" first="Steve" last="Charles">Steve Charles</name>
<name sortKey="Diaz, Rocio I" sort="Diaz, Rocio I" uniqKey="Diaz R" first="Rocio I" last="Diaz">Rocio I. Diaz</name>
<name sortKey="Randolph, John C" sort="Randolph, John C" uniqKey="Randolph J" first="John C" last="Randolph">John C. Randolph</name>
<name sortKey="Sigler, Eric J" sort="Sigler, Eric J" uniqKey="Sigler E" first="Eric J" last="Sigler">Eric J. Sigler</name>
<name sortKey="Sigler, Eric J" sort="Sigler, Eric J" uniqKey="Sigler E" first="Eric J" last="Sigler">Eric J. Sigler</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/PoplarV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001A36 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001A36 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    PoplarV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:25959143
   |texte=   25-gauge pars plana vitrectomy with medium-term postoperative perfluoro-n-octane for the repair of giant retinal tears.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:25959143" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a PoplarV1

This area was generated with Dilib version V0.6.37.
Data generation: Wed Nov 18 12:07:19 2020. Site generation: Wed Nov 18 12:16:31 2020

	Serveur d'exploration sur le peuplier
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le peuplier

25-gauge pars plana vitrectomy with medium-term postoperative perfluoro-n-octane for the repair of giant retinal tears.

25-gauge pars plana vitrectomy with medium-term postoperative perfluoro-n-octane for the repair of giant retinal tears.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki